TR200200507T2 - Androjen reseptörü modülatör bileşikleri ve metotları - Google Patents
Androjen reseptörü modülatör bileşikleri ve metotlarıInfo
- Publication number
- TR200200507T2 TR200200507T2 TR2002/00507T TR200200507T TR200200507T2 TR 200200507 T2 TR200200507 T2 TR 200200507T2 TR 2002/00507 T TR2002/00507 T TR 2002/00507T TR 200200507 T TR200200507 T TR 200200507T TR 200200507 T2 TR200200507 T2 TR 200200507T2
- Authority
- TR
- Turkey
- Prior art keywords
- methods
- androgen receptor
- receptor modulator
- modulator compounds
- compounds
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000000849 selective androgen receptor modulator Substances 0.000 title 1
- 102000001307 androgen receptors Human genes 0.000 abstract 3
- 108010080146 androgen receptors Proteins 0.000 abstract 3
- 239000000543 intermediate Substances 0.000 abstract 2
- 108010085012 Steroid Receptors Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000004031 partial agonist Substances 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000707 stereoselective effect Effects 0.000 abstract 1
- 102000005969 steroid hormone receptors Human genes 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Steroid reseptörleri tarafindan aracilik edilen proseslerin modülasyonuna yönelik bilesikler, farmasötik kompozisyonlar ve metotlar. Özellikle de androjen reseptörü (AR) için agonistler, kismi agonistler ve antagonistler olan kompozisyonlar ve steroid olmayan bilesiklerin hazirlanmasi ve kullanim metodlari tarif edilmektedir. Ayrica AR modülatörleri için ara maddelere bir stereoselektif sentetik yol da dahil olmak üzere kritik ara maddelerin imaline ve kullanimina yönelik metotlar da tarif edilmektedir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15098899P | 1999-08-27 | 1999-08-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200200507T2 true TR200200507T2 (tr) | 2002-10-21 |
Family
ID=22536855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2002/00507T TR200200507T2 (tr) | 1999-08-27 | 2000-08-25 | Androjen reseptörü modülatör bileşikleri ve metotları |
Country Status (21)
Country | Link |
---|---|
US (3) | US6462038B1 (tr) |
EP (1) | EP1212330B1 (tr) |
JP (1) | JP2003508402A (tr) |
KR (1) | KR20020038741A (tr) |
CN (1) | CN1391576A (tr) |
AT (1) | ATE323709T1 (tr) |
AU (1) | AU778655B2 (tr) |
BG (1) | BG106550A (tr) |
BR (1) | BR0013597A (tr) |
CA (1) | CA2383077A1 (tr) |
CZ (1) | CZ2002711A3 (tr) |
DE (1) | DE60027443D1 (tr) |
HU (1) | HUP0202814A3 (tr) |
IL (1) | IL148045A0 (tr) |
MX (1) | MXPA02002032A (tr) |
NO (1) | NO20020913L (tr) |
PL (1) | PL353792A1 (tr) |
SK (1) | SK2732002A3 (tr) |
TR (1) | TR200200507T2 (tr) |
WO (1) | WO2001016139A1 (tr) |
ZA (1) | ZA200201056B (tr) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0202814A3 (en) * | 1999-08-27 | 2003-11-28 | Ligand Pharmaceuticals Inc San | Androgen receptor modulator compounds and methods for their preparation and pharmaceutical compositions containing them and their use |
US6566372B1 (en) | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
IL152719A0 (en) * | 2000-06-28 | 2003-06-24 | Bristol Myers Squibb Co | Selective androgen receptor modulators and methods for their identification |
US7026484B2 (en) * | 2001-02-23 | 2006-04-11 | Ligand Pharmaceuticals Incorporated | Tricyclic androgen receptor modulator compounds and methods |
US7214690B2 (en) * | 2001-02-23 | 2007-05-08 | Ligand Pharmaceuticals Incorporated | Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods |
US6670386B2 (en) | 2001-07-31 | 2003-12-30 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
JP4746840B2 (ja) * | 2002-04-26 | 2011-08-10 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | アンドロゲン受容体モジュレーターとしての2−(キノロニル)−縮合複素環化合物 |
US7405234B2 (en) | 2002-05-17 | 2008-07-29 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
BR0312039A (pt) * | 2002-06-25 | 2005-06-28 | Wyeth Corp | Derivados ciclotiocarbamativos como moduladores de pr e uso destes para tratamento de distúrbios de pele |
MXPA05007502A (es) | 2003-01-17 | 2005-09-21 | Warner Lambert Co | Antagonistas de receptor de androgeno. |
WO2004065379A1 (en) | 2003-01-17 | 2004-08-05 | Warner-Lambert Company Llc | Androgen receptor antagonists |
BRPI0407354A (pt) | 2003-02-11 | 2006-01-10 | Warner Lambert Co | Derivados de uréia e tiouréia |
WO2004072043A1 (en) | 2003-02-11 | 2004-08-26 | Warner-Lambert Company Llc | Benzyl urea and thiourea derivatives useful as androgen antagonists |
US7009052B2 (en) | 2003-03-20 | 2006-03-07 | Warner Lambert Company Llc | Sulfonamide derivatives |
US7098340B2 (en) | 2003-05-14 | 2006-08-29 | Warner Lambert Company Llc | Benzyl sulfonamide derivatives |
JP2007500245A (ja) * | 2003-06-10 | 2007-01-11 | スミスクライン ビーチャム コーポレーション | 化合物 |
JP4709759B2 (ja) | 2003-08-22 | 2011-06-22 | リガンド・ファーマシューティカルズ・インコーポレイテッド | アンドロゲン受容体モジュレーター化合物としての6−シクロアミノ−2−キノリノン誘導体 |
CA2546601A1 (en) | 2003-11-19 | 2005-06-09 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing thyromimetics |
CN1902057A (zh) * | 2003-12-26 | 2007-01-24 | 三菱化学株式会社 | 光学记录介质和染料 |
US7820702B2 (en) | 2004-02-04 | 2010-10-26 | Bristol-Myers Squibb Company | Sulfonylpyrrolidine modulators of androgen receptor function and method |
US7625923B2 (en) | 2004-03-04 | 2009-12-01 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
US7696241B2 (en) | 2004-03-04 | 2010-04-13 | Bristol-Myers Squibb Company | Bicyclic compounds as modulators of androgen receptor function and method |
WO2005090282A1 (en) | 2004-03-12 | 2005-09-29 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
JP5070041B2 (ja) * | 2004-05-03 | 2012-11-07 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 選択的アンドローゲン受容体モジュレーター(sarms)としての新規インドール化合物 |
US7282507B2 (en) * | 2004-05-03 | 2007-10-16 | Janssen Pharmaceutica N.V. | Indole derivatives as selective androgen receptor modulators (SARMS) |
MXPA06015169A (es) * | 2004-07-08 | 2007-08-21 | Warner Lambert Co | Moduladores de androgenos. |
US7280723B2 (en) * | 2005-05-06 | 2007-10-09 | Schott Corporation | Illumination assembly including a rigid light-guiding element incorporating a numerical-aperture alteration taper |
JP5199079B2 (ja) | 2005-06-17 | 2013-05-15 | リガンド・ファーマシューティカルズ・インコーポレイテッド | アンドロゲン受容体モジュレーター化合物および方法 |
EP1916896A4 (en) * | 2005-08-26 | 2010-08-11 | Univ California | NOT STEROID-antiandrogens |
CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
US7790745B2 (en) | 2005-10-21 | 2010-09-07 | Bristol-Myers Squibb Company | Tetrahydroisoquinoline LXR Modulators |
EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
EP1942879A1 (en) | 2005-10-31 | 2008-07-16 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
JP2009536669A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | アンジオテンシン調節による神経新生 |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US8404896B2 (en) | 2006-12-01 | 2013-03-26 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
PL2222636T3 (pl) | 2007-12-21 | 2014-04-30 | Ligand Pharm Inc | Selektywne modulatory receptorów androgenowych (SARM) i ich zastosowania |
EP2130831A1 (en) | 2008-06-06 | 2009-12-09 | InterMed Discovery GmbH | CDC25 inhibitors |
US20120046364A1 (en) | 2009-02-10 | 2012-02-23 | Metabasis Therapeutics, Inc. | Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
CN108659219B (zh) * | 2018-06-08 | 2021-02-09 | 扬州大学 | 一种聚苯胺的制备方法 |
KR20220008869A (ko) | 2019-05-14 | 2022-01-21 | 누베이션 바이오 인크. | 항암 핵 호르몬 수용체-표적화 화합물 |
WO2021097046A1 (en) | 2019-11-13 | 2021-05-20 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
EP4313991A1 (en) | 2021-03-23 | 2024-02-07 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
CN117580839A (zh) | 2021-05-03 | 2024-02-20 | 诺维逊生物股份有限公司 | 抗癌核激素受体靶向化合物 |
Family Cites Families (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH590274A5 (tr) | 1970-03-16 | 1977-07-29 | Hoffmann La Roche | |
GB1379387A (en) | 1970-12-11 | 1975-01-02 | Agfa Gevaert | Photoconductive recording materials |
US3979394A (en) | 1970-12-11 | 1976-09-07 | Agfa-Gevaert N.V. | Duplo quinoline compounds |
US3755332A (en) * | 1971-07-01 | 1973-08-28 | Ciba Geigy Corp | Substituted 4 indazolaminoquinolines |
GB1400993A (en) | 1971-11-10 | 1975-07-16 | Agfa Gevaert | Electrophotographic material |
BE795696A (nl) | 1972-02-28 | 1973-08-21 | Agfa Gevaert Nv | Voor warmte gevoelige materialen |
US3936461A (en) | 1973-09-24 | 1976-02-03 | Warner-Lambert Company | Substituted 4-benzylquinolines |
US3993656A (en) | 1974-11-19 | 1976-11-23 | Merck & Co., Inc. | 1,8-Naphthyridine compounds |
US4138490A (en) | 1975-03-20 | 1979-02-06 | Imperial Chemical Industries Limited | Analgesic compositions containing 1,2-dihydro-2-oxoquinol-4-ylpropionic acid derivatives |
IE43079B1 (en) * | 1975-03-20 | 1980-12-17 | Ici Ltd | Quinolone derivatives |
SU555119A1 (ru) | 1975-05-19 | 1977-04-25 | Предприятие П/Я Г-4913 | Вулканизуема резинова смесь на основе полиизопренового каучука |
LU77254A1 (tr) | 1977-05-04 | 1979-01-18 | ||
US4579134A (en) * | 1977-09-08 | 1986-04-01 | The Bridgeport Metal Goods Manufacturing Co. | Lipstick container |
US4326055A (en) | 1977-12-22 | 1982-04-20 | Hoffmann-La Roche Inc. | Stilbene derivatives |
JPS54154797A (en) * | 1978-05-25 | 1979-12-06 | Eisai Co Ltd | Benzimidazoquinolizine derivative and antibacterials comprising it |
US4234589A (en) | 1979-09-24 | 1980-11-18 | E. R. Squibb & Sons, Inc. | Imidazolylethoxymethyl derivatives of 1,3-dioxolo quinolines |
JPS5777676A (en) | 1980-10-31 | 1982-05-15 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
DE3202100A1 (de) | 1982-01-23 | 1983-08-04 | Basf Ag, 6700 Ludwigshafen | Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen |
US4534979A (en) | 1982-06-28 | 1985-08-13 | Usv Pharmaceutical Corp. | Polyene compounds useful in the treatment of psoriasis and allergic responses |
US4427654A (en) | 1982-07-27 | 1984-01-24 | University Of Delaware | Wound healing compositions and formulations |
US4505852A (en) | 1982-11-29 | 1985-03-19 | Enzyme Systems Products | 7-Amino-4-trifluoromethylquinolone derived substrates and method for determining enzymes and inhibitors |
US4539134A (en) | 1982-12-02 | 1985-09-03 | Halliburton Company | Methods and cleaning compositions for removing organic materials from metallic surfaces |
JPS6056985A (ja) * | 1983-09-08 | 1985-04-02 | Sankyo Co Ltd | クマリン誘導体 |
US4710507A (en) | 1983-12-22 | 1987-12-01 | Pfizer Inc. | Quinolone inotropic agents |
PT80533B (en) | 1984-05-29 | 1987-04-06 | Pfizer | Process for preparing quinolone inotropic agents |
CH667868A5 (fr) | 1984-09-05 | 1988-11-15 | Oreal | Derives du benzonorbornene, leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant. |
DE3434944A1 (de) | 1984-09-22 | 1986-04-03 | Basf Ag, 6700 Ludwigshafen | L-substituierte tetralinderivate, ihre herstellung und verwendung |
FR2580277B1 (fr) | 1985-04-15 | 1988-06-10 | Oreal | Nouveaux derives naphtaleniques a action retinoique, le ur procede de preparation et compositions medicamenteuse et cosmetique les contenant |
LU86022A1 (fr) | 1985-07-25 | 1987-02-04 | Cird | Derives aromatiques polycyliques,leur procede de preparation et leur application dans les domaines pharmaceutique et cosmetique |
JPS62215581A (ja) | 1986-03-18 | 1987-09-22 | Koichi Shiyudo | フラボンカルボン酸誘導体 |
FR2601670B1 (fr) | 1986-07-17 | 1988-10-07 | Cird | Nouveaux derives bicycliques aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique |
US5071773A (en) | 1986-10-24 | 1991-12-10 | The Salk Institute For Biological Studies | Hormone receptor-related bioassays |
FR2605626B1 (fr) | 1986-10-27 | 1989-06-02 | Oreal | Nouveaux derives aromatiques bicycliques, leur procede de preparation et leur utilisation en cosmetique et en medecine humaine et veterinaire |
US5081242A (en) | 1986-12-22 | 1992-01-14 | Ortho Pharmaceutical Corporation | 6-benzoxazinyl- and 6-benzothiazinyl 2,3,4,5-tetrahydropyridazin-3-ones |
GB8630702D0 (en) | 1986-12-23 | 1987-02-04 | Wellcome Found | Quinoline compound |
FR2614618B1 (fr) | 1987-04-30 | 1989-07-07 | Cird | Derives heterocycliques polycycliques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire |
EP0303418A3 (en) | 1987-08-11 | 1990-11-07 | Smithkline Beecham Laboratoires Pharmaceutiques | Substituted indolones, useful in the treatment of heart or asthmatic diseases |
LU87040A1 (fr) | 1987-11-04 | 1989-06-14 | Oreal | Esters aromatiques polycycliques d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant |
US4981784A (en) | 1987-12-02 | 1991-01-01 | The Salk Institute For Biological Studies | Retinoic acid receptor method |
WO1989007441A1 (en) | 1988-02-10 | 1989-08-24 | The Regents Of The University Of California | 6-amino-1,2-benzopyrone antitumorigenic agents and method |
DE3810706A1 (de) | 1988-03-25 | 1989-10-05 | Schering Ag | Substituierte cumarinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider wirkung |
EP0347960B1 (en) | 1988-06-23 | 1994-07-06 | Agfa-Gevaert N.V. | Photosensitive recording material suited for use in electrophotography |
GB8820174D0 (en) | 1988-08-25 | 1988-09-28 | Wellcome Found | Quinoline compound |
US5108486A (en) * | 1990-02-09 | 1992-04-28 | Kanagawa Chemical Laboratory, Ltd. | Herbicidal substituted-phenyl-1,2,4-triazol-5(1H)-thiones and -ones |
US5091528A (en) | 1990-09-12 | 1992-02-25 | Allergan, Inc. | 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents |
DE4036779A1 (de) | 1990-11-17 | 1992-05-21 | Basf Ag | Verwendung von arylpolyencarbonsaeuren und ihren derivaten als lichtschutzmittel in kosmetischen zubereitungen |
US5147844A (en) | 1991-06-14 | 1992-09-15 | Eastman Kodak Company | Mixture on cyan and yellow dyes to form a green hue for color filter array element |
FR2683818B1 (fr) | 1991-11-14 | 1993-12-31 | Adir Cie | Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
DE10199033I2 (de) | 1992-04-22 | 2003-01-09 | Ligand Parmaceuticals Inc | Retinoid-x Rezeptor selektive Verbindungen |
CA2093577C (en) | 1992-05-07 | 2006-01-03 | Michael Klaus | Alkyl or alkoxy substituted s-heterocyclic retinoids |
NZ248794A (en) | 1992-09-29 | 1995-01-27 | Adir | 3-carboxy-(and phosphonoxy-)alkatriene-substituted chromene derivatives and medicaments |
JPH08506323A (ja) | 1992-11-25 | 1996-07-09 | ラ ホヤ キャンサー リサーチ ファウンデーション | Rxrホモダイマー形成ならびに架橋二環式芳香族化合物および調節遺伝子発現におけるそれらの使用 |
AU6225894A (en) | 1993-01-11 | 1994-08-15 | Ligand Pharmaceuticals, Inc. | Compounds having selectivity for retinoid x receptors |
WO1994015901A1 (en) | 1993-01-11 | 1994-07-21 | Ligand Pharmaceuticals Inc. | Compounds having selectivity for retinoid x receptors |
US5455265A (en) | 1993-02-11 | 1995-10-03 | Allergan, Inc. | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors |
US5399586A (en) | 1993-03-11 | 1995-03-21 | Allergan, Inc. | Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity |
US5677336A (en) * | 1993-10-21 | 1997-10-14 | Ligand Pharmaceuticals Incorporated | Non-steroid androgen receptor antagonist compounds and methods |
CA2184392A1 (en) | 1994-03-08 | 1995-09-14 | Takashi Sohda | Quinoline or quinazoline derivatives as anti-inflammatory agents, in particular for treating arthritis |
FR2719041B1 (fr) | 1994-04-26 | 1996-05-31 | Cird Galderma | Nouveaux composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations. |
CA2196197C (en) | 1994-08-10 | 2007-04-17 | Michael Klaus | Retinoic acid x-receptor ligands |
US5977125A (en) | 1994-10-31 | 1999-11-02 | Eisai Co., Ltd. | Mono-or polyenic carboxylic acid derivatives |
IL116259A (en) | 1994-12-19 | 2000-07-16 | American Cyanamid Co | Analogs of 9-cis retinoic acid and their use |
US5968908A (en) | 1994-12-19 | 1999-10-19 | American Cyanamid Company | Restricted 9-cis retinoids |
US6696459B1 (en) * | 1994-12-22 | 2004-02-24 | Ligand Pharmaceuticals Inc. | Steroid receptor modulator compounds and methods |
US5696127A (en) | 1994-12-22 | 1997-12-09 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
DK0800519T3 (da) | 1994-12-22 | 2004-03-01 | Ligand Pharm Inc | Steroidreceptormodulatorforbindelser og fremgangsmåder |
US5721103A (en) | 1994-12-30 | 1998-02-24 | Ligand Pharmaceuticals Incorporated | Trienoic retinoid compounds and methods |
AU712187B2 (en) | 1994-12-30 | 1999-10-28 | Ligand Pharmaceuticals Incorporated | Novel trienoic retinoid compounds and methods |
DK1251125T3 (da) * | 1995-06-21 | 2006-04-18 | Sod Conseils Rech Applic | Hidtil ukendte camptothecin-analoger, fremgangsmåde til fremstilling heraf, anvendelse heraf som lægemidler og farmaceutiske præparater indeholdende disse |
JP3964478B2 (ja) | 1995-06-30 | 2007-08-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬 |
WO1997007120A1 (en) * | 1995-08-11 | 1997-02-27 | Smithkline Beecham Plc | Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht1d receptor antagonists |
US5776699A (en) | 1995-09-01 | 1998-07-07 | Allergan, Inc. | Method of identifying negative hormone and/or antagonist activities |
ES2190479T3 (es) | 1995-10-06 | 2003-08-01 | Ligand Pharm Inc | Moduladores de rxr selectivos a dimeros y metodos para su uso. |
AU728178B2 (en) | 1996-06-27 | 2001-01-04 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
US6017924A (en) * | 1996-06-27 | 2000-01-25 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
FR2752837B1 (fr) | 1996-09-02 | 1999-11-12 | Cird Galderma | Nouveaux composes modulateurs des recepteurs hormonaux, les compositions les comprenant et leur utilisation en therapie |
ATE334673T1 (de) | 1997-11-12 | 2006-08-15 | Hoffmann La Roche | Behandlung von t-helfer zel typ 2 vermittelten immunkrankheiten mit retinoid antagonisten |
US6001846A (en) * | 1998-02-17 | 1999-12-14 | Ligand Pharmaceuticals Incorporated | Process for the preparation of 1,2-dihydroquinolines |
JPH11242304A (ja) * | 1998-02-26 | 1999-09-07 | Konica Corp | 熱現像感光材料 |
EP1056775B1 (en) | 1998-02-27 | 2010-04-28 | Novo Nordisk A/S | Glp-1 derivatives of glp-1 and exendin with protracted profile of action |
EP1077919A1 (en) | 1998-05-11 | 2001-02-28 | Novo Nordisk A/S | New compounds, their preparation and use |
US6093826A (en) * | 1998-06-08 | 2000-07-25 | Ligand Pharmaceuticals Incorporated | Process for the preparation of C(5)-substituted 1,2-dihydro-5H-chromeno[3,4-f] quinolines |
US6147224A (en) | 1998-10-01 | 2000-11-14 | Allergan Sales, Inc. | 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
WO2000053562A1 (en) | 1999-03-08 | 2000-09-14 | Basilea Pharmaceutica Ag | Retinoid antagonists and use thereof |
AT407876B (de) | 1999-04-30 | 2001-07-25 | Georg Dr Uray | Lumineszierende 4-trifluormethyl-2-chinolinone mit langwelliger uv-absorption und ihre verwendung |
US6566372B1 (en) * | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
HUP0202814A3 (en) * | 1999-08-27 | 2003-11-28 | Ligand Pharmaceuticals Inc San | Androgen receptor modulator compounds and methods for their preparation and pharmaceutical compositions containing them and their use |
WO2001016133A2 (en) * | 1999-08-27 | 2001-03-08 | Ligand Pharmaceuticals Incorporated | 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
US6172241B1 (en) * | 1999-10-15 | 2001-01-09 | Ligand Pharmaceuticals Incorporated | Process for the preparation of 1,2-dihydroquinolines |
US7026484B2 (en) * | 2001-02-23 | 2006-04-11 | Ligand Pharmaceuticals Incorporated | Tricyclic androgen receptor modulator compounds and methods |
US7214690B2 (en) * | 2001-02-23 | 2007-05-08 | Ligand Pharmaceuticals Incorporated | Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods |
US6670386B2 (en) * | 2001-07-31 | 2003-12-30 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
-
2000
- 2000-08-25 HU HU0202814A patent/HUP0202814A3/hu unknown
- 2000-08-25 AU AU69414/00A patent/AU778655B2/en not_active Ceased
- 2000-08-25 JP JP2001519705A patent/JP2003508402A/ja active Pending
- 2000-08-25 US US09/648,684 patent/US6462038B1/en not_active Expired - Lifetime
- 2000-08-25 MX MXPA02002032A patent/MXPA02002032A/es active IP Right Grant
- 2000-08-25 DE DE60027443T patent/DE60027443D1/de not_active Expired - Lifetime
- 2000-08-25 AT AT00957854T patent/ATE323709T1/de not_active IP Right Cessation
- 2000-08-25 CZ CZ2002711A patent/CZ2002711A3/cs unknown
- 2000-08-25 WO PCT/US2000/023520 patent/WO2001016139A1/en active IP Right Grant
- 2000-08-25 KR KR1020027002613A patent/KR20020038741A/ko not_active Application Discontinuation
- 2000-08-25 BR BR0013597-6A patent/BR0013597A/pt not_active Application Discontinuation
- 2000-08-25 CN CN00814951A patent/CN1391576A/zh active Pending
- 2000-08-25 IL IL14804500A patent/IL148045A0/xx unknown
- 2000-08-25 PL PL00353792A patent/PL353792A1/xx not_active Application Discontinuation
- 2000-08-25 SK SK273-2002A patent/SK2732002A3/sk unknown
- 2000-08-25 TR TR2002/00507T patent/TR200200507T2/tr unknown
- 2000-08-25 CA CA002383077A patent/CA2383077A1/en not_active Abandoned
- 2000-08-25 EP EP00957854A patent/EP1212330B1/en not_active Expired - Lifetime
-
2002
- 2002-02-06 ZA ZA200201056A patent/ZA200201056B/xx unknown
- 2002-02-25 NO NO20020913A patent/NO20020913L/no unknown
- 2002-03-25 BG BG106550A patent/BG106550A/xx unknown
- 2002-09-09 US US10/238,363 patent/US20030186970A1/en not_active Abandoned
-
2006
- 2006-01-25 US US11/340,282 patent/US20070167445A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001016139A1 (en) | 2001-03-08 |
CZ2002711A3 (cs) | 2003-11-12 |
DE60027443D1 (de) | 2006-05-24 |
WO2001016139A9 (en) | 2002-09-19 |
US20070167445A1 (en) | 2007-07-19 |
MXPA02002032A (es) | 2003-05-19 |
AU6941400A (en) | 2001-03-26 |
CA2383077A1 (en) | 2001-03-08 |
BG106550A (en) | 2002-10-31 |
EP1212330B1 (en) | 2006-04-19 |
US20030186970A1 (en) | 2003-10-02 |
IL148045A0 (en) | 2002-09-12 |
PL353792A1 (en) | 2003-12-01 |
NO20020913L (no) | 2002-04-29 |
JP2003508402A (ja) | 2003-03-04 |
EP1212330A1 (en) | 2002-06-12 |
NO20020913D0 (no) | 2002-02-25 |
KR20020038741A (ko) | 2002-05-23 |
ZA200201056B (en) | 2003-07-30 |
CN1391576A (zh) | 2003-01-15 |
HUP0202814A3 (en) | 2003-11-28 |
US6462038B1 (en) | 2002-10-08 |
BR0013597A (pt) | 2002-07-16 |
AU778655B2 (en) | 2004-12-16 |
HUP0202814A2 (hu) | 2002-12-28 |
ATE323709T1 (de) | 2006-05-15 |
SK2732002A3 (en) | 2002-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200200507T2 (tr) | Androjen reseptörü modülatör bileşikleri ve metotları | |
TR200200508T2 (tr) | Bisayklik androjen ve projesteron reseptörü modülatör bileşikleri ve metodları. | |
BR0010215A (pt) | Derivados de indolina como antagonistas de progesterona | |
ES2168650T3 (es) | Compuestos y metodos moduladores de receptores de androgenos. | |
AP1542A (en) | Glucocorticoid receptor modulators. | |
AU2003228283A1 (en) | Quinazolinone modulators of nuclear receptors | |
HN1998000157A (es) | Agonistas de prostaglandinas | |
BR0104836A (pt) | Processo para a preparação de moduladores de receptores de glucocorticóides não-esteroidais | |
UY24986A1 (es) | Compuestos | |
WO2001016133A3 (en) | 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators | |
YU83600A (sh) | Adenozin a3 receptorski modulatori | |
NO985242D0 (no) | Tetrahydroisokinolin-derivater som modulatorer for dopamin D3-reseptorer | |
AU2002367060A8 (en) | Heterocyclic modulators of nuclear receptors | |
BR0207543A (pt) | Quinolinona tricìclica e quinolina tricìclica como compostos moduladores de receptor de androgênio | |
TR200002896T2 (tr) | Kalsilitik Bileşimler | |
SV2002000005A (es) | Heterociclos 2-arilimino substituidos y composiciones que los contienen para usar como agentes que ligan el receptor de la progesterona ref. 5048p1-sv | |
BRPI0507987A (pt) | métodos e compostos moduladores receptor de glicocorticóide | |
ATE437853T1 (de) | Glucocorticoid-rezeptoren-modulatoren | |
HK1047752A1 (zh) | 具有核激素受體調節活性的有機硅化合物 | |
CR6398A (es) | Antagonistas de 5ht1 para terapia antidepresiva | |
ATE375985T1 (de) | Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten | |
SE9904660D0 (sv) | Novel assays | |
ATE305925T1 (de) | Positive modulatoren von nicotinrezeptor- agonisten | |
UY26809A1 (es) | Moduladores cíclicos fusionados de función de receptor hormonal nuclear | |
NO20015378L (no) | Cyklokarbamatderivater som progesteronreseptormodulatorer |